Celgene initiates Canadian clinical trial program for chirally pure form of Ritalin Feb. 17, 1999 No Comments
Potent, selective and orally bioavailable 5-ht6 receptor antagonist presented by SB Feb. 17, 1999 No Comments
Promising results obtained with activated immune cell therapies in development at Proneuron Feb. 15, 1999 No Comments
RSS